This meeting took place in 2017

Here are the related meetings in 2020:
Advances in Cancer Immunotherapy (C4)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology (C7)

Organizer(s) Robert D. Schreiber, James P. Allison, Philip D. Greenberg and Glenn Dranoff
March 19—23, 2017
Fairmont Chateau Whistler • Whistler, BC Canada
Discounted Abstract Deadline: Nov 16, 2016
Abstract Deadline: Dec 19, 2016
Scholarship Deadline: Nov 16, 2016
Discounted Registration Deadline: Jan 18, 2017

Sponsored by Astellas Pharma Inc., AstraZeneca, BioLegend, Inc., Bristol-Myers Squibb Company, Cell Research, Cell Signaling Technology, Inc., Genentech, Inc., Genmab A/S, ImmunoGen, Inc., Incyte Corporation, Juno Therapeutics, Merck & Co., Inc., Mersana Therapeutics, MorphoSys AG, OncoMed Pharmaceuticals, Inc. ,Pfizer Inc., Regeneron Pharmaceuticals, Inc., Roche, Sangamo Therapeutics, Inc., Takeda Pharmaceutical Company Limited and TESARO, Inc. Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.

Summary of Meeting:
The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Keystone Symposia meeting is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients. Part of the meeting will also focus on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past.

View Meeting Program


Keystone Symposia Future of Science Fund Scholarship Recipients

Frederick Arce Vargas
University College of London, UK

Riccardo Mezzadra
NKI-AvL, Netherlands

National Cancer Institute (NCI) Scholarship Recipients

Kristin Anderson
University of Washington, USA

Yulong Aaron Gao
QIMR Berghofer Medical Research Institute, Australia

Hayley S. Ma
Kineta Inc., USA

Brian Christopher Miller
Dana-Farber Cancer Institute, USA

Alice Tzeng
Cleveland Clinic Lerner College of Medicine, USA

Spencer C. Wei
University of Texas MD Anderson Cancer Center, USA

Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation

Lynda Addo
University of Ghana, Ghana

Denise da Gama Jaén Batista
Oswaldo Cruz Institute - Oswaldo Cruz Foundation, Brazil

Felix E. Emele
Nnamdi Azikiwe Universty, Nigeria

Ana Farias
Fundación Instituto Leloir, Argentina

Gerardo Alberto Gatti
Fundación para el Progreso de la Medicina, Argentina

Shadab Kazmi
, India

Soledad Mac Keon
Fundación Instituto Leloir, Argentina

Yogeeswari Perumal
BITS-Pilani, Hyderabad Campus, India

Yanti Yanti
Atma Jaya Catholic University, Indonesia